General Information of Drug Formulation (ID: F14853)

Formulation Name
Naloxegol 25 mg tablet
Company
AstraZeneca; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Naloxegol DML0B41 Opioid-induced constipation DB32.1 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Eisenoxyd E00585 56841934 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 400 E00653 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Propyl gallate E00075 4947 Antimicrobial preservative; Antioxidant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Water E00035 962 Solvent